Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-12

FDA Approved: PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE — Original Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' generic phentermine/topiramate extended-release (ANDA) for obesity, marking the generic approval of this combination ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine and Topiramate Extended-Release (phentermine/topiramate extended-release)

Snippet

ORIG AP for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE (PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE)